SCHEMBL89187

SCHEMBL89187

O=C(O)C=Cc1ccc(O)cc1O

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MIF P14174 1/20 0.68
TYR P14679 3/20 0.67
CHRNA7 P36544 7/20 0.66
CA1 P00915 2/20 0.60
CA2 P00918 2/20 0.60
CA4 P22748 2/20 0.60
NFKB1 P19838 1/20 0.60
BACE1 P56817 1/20 0.60
MGAM O43451 1/20 0.56
GAA P10253 1/20 0.56
SI P14410 1/20 0.56
MGAM2 Q2M2H8 1/20 0.56
CA12 O43570 1/20 0.53
AKR1B10 O60218 1/20 0.53
ESR1 P03372 1/20 0.53
CA3 P07451 1/20 0.53
PKM P14618 1/20 0.53
AKR1B1 P15121 1/20 0.53
CA6 P23280 1/20 0.53
DPP4 P27487 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL471946 1.00 MIF (0.68) MIFTYRCHRNA7CA1CA2
SCHEMBL28391865 1.00 MIF (0.68) MIFTYRCHRNA7CA1CA2
SCHEMBL28140874 1.00 MIF (0.68) MIFTYRCHRNA7CA1CA2
SCHEMBL11461920 0.98 MIF (0.66) MIFTYRCHRNA7CA1CA2
SCHEMBL27576656 0.98 MIF (0.66) MIFTYRCHRNA7CA1CA2
SCHEMBL29065212 0.93 CHRNA7 (0.61) MIFTYRCHRNA7CA1CA2
SCHEMBL29065213 0.93 CHRNA7 (0.61) MIFTYRCHRNA7CA1CA2
Coumaric Acid SCHEMBL28848354 0.91 BACE1 (0.74) MIFTYRCHRNA7CA1CA2
SCHEMBL4653698 0.86 CHRNA7 (0.68) TYRCHRNA7NFKB1BACE1MGAM
SCHEMBL4653701 0.86 CHRNA7 (0.68) TYRCHRNA7NFKB1BACE1MGAM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 3013 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12391981-B2 Chromogenic peroxidase substrates AGILENT TECHNOLOGIES, INC. (US) 2025-08-19 US claimed
WO-2025081932-A1 RETINOL DERIVATIVE OR SALT THEREOF, AS WELL AS PREPARATION METHOD THEREFOR AND USE THEREOF 深圳市护家科技有限公司 2025-04-24 WO claimed
CN-119841755-A Retinol derivative or its salt, and preparation method and application thereof 深圳市护家科技有限公司 2025-04-18 CN claimed
US-20250092179-A1 PHOTOSTABLE COMPOSITIONS COMPRISING PARA-ALKOXYL PHENYL SUBSTITUTED PROPENOIC ACID (APP) COPOLYMER DERIVATIVES HallStar Beauty and Personal Care Innovations Company 2025-03-20 US claimed
US-12162972-B2 Photostable compositions comprising para-alkoxyl phenyl substituted propenoic acid (APP) copolymer derivatives HallStar Beauty and Personal Care Innovations Company (US) 2024-12-10 US claimed
US-20240360495-A1 CHROMOGENIC PEROXIDASE SUBSTRATES DAKO DENMARK APS (DK) 2024-10-31 US claimed
WO-2024209462-A1 ANTI-BIOFILM POLYMER COMPOSITIONS YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) 2024-10-10 WO claimed
CN-118615211-A Mask composition and preparation method thereof 上海金沣铭生物科技有限公司 2024-09-10 CN claimed
US-11993810-B2 Chromogenic peroxidase substrates AGILENT TECHNOLOGIES, INC. (US) 2024-05-28 US claimed
CN-117965115-A Adhesive for salt lake lithium extraction adsorbent, adsorbent and preparation method thereof 天齐锂业(射洪)有限公司 2024-05-03 CN claimed
EP-0514467-B1 COMPOSITIONS AND METHODS FOR INHIBITING BROWNING IN FOODS OPTA FOOD INGREDIENTS INC (US) 1994-08-10 EP claimed
US-5281538-A Method of preparing a sample for analysis by laser desorption mass spectrometry FINNIGAN MAT LIMITED (GB) 1994-01-25 US claimed
EP-0514467-A1 COMPOSITIONS AND METHODS FOR INHIBITING BROWNING IN FOODS. OPTA FOOD INGREDIENTS INC (US) 1992-11-25 EP claimed
WO-1991011119-A1 COMPOSITIONS AND METHODS FOR INHIBITING BROWNING IN FOODS OPTA FOOD INGREDIENTS, INC. (US) 1991-08-08 WO claimed
CN-1040142-A Oral composition PROCTER & GAMBLE (US) 1990-03-07 CN claimed
US-4302199-A Hair dyeing method THE PROCTER & GAMBLE COMPANY (US) 1981-11-24 US claimed
EP-0036534-A1 An orally administrable drug form comprising a beta-lactam antibiotic and an adjuvant INTERx RESEARCH CORPORATION (US) 1981-09-30 EP claimed
EP-0036145-A1 An orally administered drug form comprising a polar bioactive agent and an adjuvant INTERx RESEARCH CORPORATION (US) 1981-09-23 EP claimed
EP-0035770-A2 An orally administered drug form comprising a glycosidic antibiotic and an adjuvant INTERx RESEARCH CORPORATION (US) 1981-09-16 EP claimed
EP-0031561-A2 A rectally administered suppository comprising a drug and an adjuvant MERCK & CO. INC. (US) 1981-07-08 EP claimed